Historical record - last NADAC effective date: 7/17/2024
Product Information
ROPINIROLE HCL 0.25 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0400 per EA under NDC 16729023201. Its NADAC has been published 301 times since Nov 14, 2018.
FDA first approved this application on Feb 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.25 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729023201
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/17/2024
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204022FDA Approved
2/28/2017
TE Code
AB
On Market Since
10/17/2018
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 0.25 MG TABLET has been published 301 times since Nov 14, 2018, and over the history we have for it it has declined 41.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0400 per EA |
|---|---|
| All-time high | $0.0710 (Apr 15, 2020) |
| All-time low | $0.0400 (Jul 17, 2024) |
| Median price | $0.0566 |
| Average price | $0.0566 |
| Largest weekly change | +17.3% (Jan 19, 2022) |
| Weeks tracked | 301 |
| Tracking since | Nov 14, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-18.4%
5Y
-34.9%
All
-41.4%
Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 0.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 0.25 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0400 per EA (NDC 16729023201), effective Aug 14, 2024.
How has the price of ROPINIROLE HCL 0.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 0.25 MG TABLET has declined 41.4%. It has been tracked across 301 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 0.25 MG TABLET?
Since Nov 14, 2018, the NADAC for ROPINIROLE HCL 0.25 MG TABLET has ranged from a low of $0.0400 (Jul 17, 2024) to a high of $0.0710 (Apr 15, 2020), with a median of $0.0566 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 0.25 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ROPINIROLE HCL 0.25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ROPINIROLE HCL 0.25 MG TABLET?
ROPINIROLE HCL 0.25 MG TABLET (NDC 16729023201) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.